According to the recent study the global pharmaceutical contract manufacturing market is projected to reach an estimated $297 billion by 2030 at a CAGR of 8% from 2024 to 2030. Growth in this market is primarily driven by growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.
A more than 150–page
report is developed to understand trends, opportunities and forecast in global pharmaceutical
contract manufacturing market by services (manufacturing [API, FDF (parenteral,
injectable, tablet, capsule, and oral liquid)], drug development, and biologics
manufacturing), end use industry (big pharmaceutical, small & medium-sized pharmaceutical,
and generic pharmaceutical), and region (North America, Europe, Asia Pacific,
and the Rest of the World).
Download sample by clicking on
pharmaceutical
contract manufacturing market.
Lucintel forecasts that
biologics manufacturing will remain the largest segment over the forecast
period due to increasing need for producing vaccines and biosimilars.
Within this market, big
pharmaceutical segment is expected to remain the largest segment due to growing
trend among large pharmacies to contract out pharmaceutical production in order
to minimize the pricing pressure and pipeline issues in their operations along
with increasing demand for optimization of execution costs as bestselling
medication patents expires.
APAC is expected to
remain the largest region due to increasing demand from geriatric population,
growing outsourcing activities and expansion of manufacturing capabilities of
the local key players in the region.
Thermo Fisher
Scientific, Catalent, Lonza, Almac Group, Recipharm, Patheon, Grifols
International, Dalton Pharma Services, and AbbVie are the major suppliers in
the pharmaceutical contract manufacturing market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Tax Management Software Market
Absolute Optical Encoder Market
Compostable Plastic Packaging Market
No comments:
Post a Comment